Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (501-510 of 1,058) with videos related to

Pageof 106
Sort By:
Leukemia & Lymphoma|August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461J C Byrd, D Lawrence, D C Arthur, et al.
Blood Advances|July 25, 2019
Challenges and approaches to implementing master/basket trials in oncologyAmy Burd, Richard L Schilsky, John C Byrd, et al.
Annals of Hematology|March 7, 2006
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphomaCarl R Willis, Amy Goodrich, Kathy Park, et al.
The Annals of Pharmacotherapy|May 10, 2013
Pharmacist-physician collaboration for diabetes care: the diabetes initiative programMichelle Zingone Farland, Debbie C Byrd, M Shawn McFarland, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 20, 2015
Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia ModelPatrick D Halley, Christopher R Lucas, Emily M McWilliams, et al.
The Journal of Organic Chemistry|February 28, 2020
Synthesis of Erythritol Tetranitrate Derivatives: Functional Group Tuning of Explosive SensitivityNicholas Lease, Lisa M Kay, Geoffrey W Brown, et al.
Journal of Hematology & Oncology|November 15, 2022
Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemiaElizabeth M Muhowski, Janani Ravikrishnan, Britten Gordon, et al.
Leukemia Research|September 10, 2015
BRAF<sup>V600E</sup> induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activationYo-Ting Tsai, Gerard Lozanski, Amy Lehman, et al.
Leukemia|February 20, 2009
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphomaJ A Woyach, T S Lin, M S Lucas, et al.
Pageof 106

Showing results (501-510 of 1,058) with videos related to

Sort By:
Pageof 106
Leukemia & Lymphoma|August 20, 2013
Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca B Klisovic, Ramiro Garzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461J C Byrd, D Lawrence, D C Arthur, et al.
Blood Advances|July 25, 2019
Challenges and approaches to implementing master/basket trials in oncologyAmy Burd, Richard L Schilsky, John C Byrd, et al.
Annals of Hematology|March 7, 2006
A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphomaCarl R Willis, Amy Goodrich, Kathy Park, et al.
The Annals of Pharmacotherapy|May 10, 2013
Pharmacist-physician collaboration for diabetes care: the diabetes initiative programMichelle Zingone Farland, Debbie C Byrd, M Shawn McFarland, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 20, 2015
Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia ModelPatrick D Halley, Christopher R Lucas, Emily M McWilliams, et al.
The Journal of Organic Chemistry|February 28, 2020
Synthesis of Erythritol Tetranitrate Derivatives: Functional Group Tuning of Explosive SensitivityNicholas Lease, Lisa M Kay, Geoffrey W Brown, et al.
Journal of Hematology & Oncology|November 15, 2022
Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemiaElizabeth M Muhowski, Janani Ravikrishnan, Britten Gordon, et al.
Leukemia Research|September 10, 2015
BRAF<sup>V600E</sup> induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activationYo-Ting Tsai, Gerard Lozanski, Amy Lehman, et al.
Leukemia|February 20, 2009
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphomaJ A Woyach, T S Lin, M S Lucas, et al.
Pageof 106